| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/16/2009 | CN101531656A Lamivudine crystal form and preparation method thereof |
| 09/16/2009 | CN101531653A Salts of 3-(4-amino-1-oxo-1,3-dihydro-iso-indol-2-yl)piperdine-2,6-dione and derivatives thereof, polymorph of the salts, preparation and application thereof |
| 09/16/2009 | CN101531649A Method for preparing andrographolide derivatives and preparation thereof |
| 09/16/2009 | CN101531644A New daphnane diterpene compounds in Daphne genkwa as well as preparation method and application of same |
| 09/16/2009 | CN101531642A Method for preparing pinaverium bromide and application thereof |
| 09/16/2009 | CN101531638A Compound used as a regulator of estrogen-related receptor and applications thereof |
| 09/16/2009 | CN101531637A A novel compound capable of restraining and blocking M2 ion channel activity and application thereof |
| 09/16/2009 | CN101531613A Aminopeptidase N inhibitor bestatin dino ester, synthesis and application thereof |
| 09/16/2009 | CN101531579A Diaromatic compound with bioactivity |
| 09/16/2009 | CN101531570A 1,2,3-substituted-5-acetylenyl-(or 10,11-dihydro)-5H-diphenyl[a,d] suberne (alkyl)-5-alcohol, synthesizing method and application |
| 09/16/2009 | CN101531563A Chemical complexing directional separation and purification method for preparing high-purity beta-elemene raw material medicament |
| 09/16/2009 | CN101530620A Triphosadenine intercalated houghite membrane and preparation method thereof |
| 09/16/2009 | CN101530619A Method for preparing water soluble pegylation hydroxycamptothecine derivatives |
| 09/16/2009 | CN101530618A Pharmaceutical composition for the treatment of chronic obstructive pulmonary disease and bronchial asthma |
| 09/16/2009 | CN101530617A Pharmaceutical composition containing PPAR regulator and strontium salt |
| 09/16/2009 | CN101530610A Composition for cleaning liver and gall toxin |
| 09/16/2009 | CN101530589A Chinese medicinal preparation for treating cancers |
| 09/16/2009 | CN101530583A Composition and preparation method of thin paste for treating pain and numbness |
| 09/16/2009 | CN101530574A Traditional Chinese medicine composite capable of treating dysfunctional uterine bleeding |
| 09/16/2009 | CN101530571A Method for preparing tea seed oil burn wound ointment |
| 09/16/2009 | CN101530560A External medicament for treating burn and scald and preparation method thereof |
| 09/16/2009 | CN101530548A Composition with multiple health-care functions and preparation method thereof |
| 09/16/2009 | CN101530547A Cough-relieving traditional Chinese medicinal composition and preparation method thereof |
| 09/16/2009 | CN101530545A Quality standard for musk analgesic spray Chinese medicinal preparation and inspection method thereof |
| 09/16/2009 | CN101530542A Oral pharmaceutical preparation of chinaroot greenbrier total aglycon and preparation method and application thereof |
| 09/16/2009 | CN101530533A Oral pharmaceutical preparation of dioscorea zingiberensis wright total sapogenin and preparation method and application thereof |
| 09/16/2009 | CN101530521A Powdered medicine with special effect for eliminating pain of heel |
| 09/16/2009 | CN101530519A Electrothermal plaster for treating mastitis or mastosis |
| 09/16/2009 | CN101530518A Traditional Chinese medicine composition for treating hemorrhoids and preparation method thereof |
| 09/16/2009 | CN101530494A Substance for intestinal tract lavation and toxin expelling and preparation method thereof |
| 09/16/2009 | CN101530487A Application of rubus parvifolius saponin series compound in preparing medicines for treating prostatitis disease |
| 09/16/2009 | CN101530485A Bone ache liquid |
| 09/16/2009 | CN101530480A Quality inspection method for quick-acting cardiac pain spray |
| 09/16/2009 | CN101530477A Powdered medicine for eliminating pain and relieving swollen |
| 09/16/2009 | CN101530467A Protection effect of compound Danshen dropping pill on cordis microcirculatory disturbance and myocardial damage |
| 09/16/2009 | CN101530466A Nano medicament containing oregano oil and vitamins |
| 09/16/2009 | CN101530462A Composition for treating eczema and preparation method thereof |
| 09/16/2009 | CN101530460A Line products of alcohol-relieving and liver-protecting preparation |
| 09/16/2009 | CN101530448A External Chinese medicinal plaster for treating traumatic injury |
| 09/16/2009 | CN101530428A Artificial bezoar and preparation method thereof |
| 09/16/2009 | CN101530426A Kazakstan skeleton softening medicine |
| 09/16/2009 | CN101530422A Liquid-phase adenosine triphosphate coupled nanometer simple substance selenium and preparation and storage method thereof |
| 09/16/2009 | CN101530420A Application of tunicamycin in preparing tumour cell reversing drug |
| 09/16/2009 | CN101530419A Application of dammarane triterpenes derivative and drug composition containing dammarane triterpenes derivative |
| 09/16/2009 | CN101530418A A pharmaceutical formulation for treating skin sensibility |
| 09/16/2009 | CN101530417A Application of mulberry skin glucoside in preventing and treating hyperuricemia and gout |
| 09/16/2009 | CN101530416A Composition containing adefovir dipivoxil, and preparation method thereof |
| 09/16/2009 | CN101530415A Pharmaceutical composition containing bisphosphates and preparation method thereof |
| 09/16/2009 | CN101530414A Applications of compound ketanserin |
| 09/16/2009 | CN101530413A Combined medicament for treating headache |
| 09/16/2009 | CN101530412A Pharmaceutical composition of blonanserin and preparation method thereof |
| 09/16/2009 | CN101530411A Application for taking NO donor-type compounds as P-glycoprotein inhibitors and tumor multi-drug resistance reversal agents |
| 09/16/2009 | CN101530410A Application of oligomeric proantho cyanidins in preparing products resisting vascular dementia |
| 09/16/2009 | CN101530409A Thrombi-resistant application of salvianolic acid B |
| 09/16/2009 | CN101530408A Antineoplastic medicine composition and application thereof |
| 09/16/2009 | CN101530407A Hair growing preparation for treating androgenetic alopecia and preparation method thereof |
| 09/16/2009 | CN101530406A Compound enteric-coated preparation and preparation method thereof |
| 09/16/2009 | CN101530405A Citric acid and compound citric acid application in pharmacy |
| 09/16/2009 | CN101530404A Thrombi-resistant application of dihydroxyphenyl lactate |
| 09/16/2009 | CN101530403A Xylitol compound for curing or preventing female colpitis and cervical erosion |
| 09/16/2009 | CN101530401A Compound transdermal patch used for curing acute and chronic inflammatory pain |
| 09/16/2009 | CN101530400A Effervescence tablet capable of treating penis erection dysfunction and preparation method thereof |
| 09/16/2009 | CN101530399A Silibinin solid self-emusifying tablet and preparation method thereof |
| 09/16/2009 | CN101530397A Phloroglucinol freeze-dried powder injection composition for injection |
| 09/16/2009 | CN101530396A Method for preparing an amlodipine microsphere |
| 09/16/2009 | CN101530394A Polypeptide-chitosan composite nanoparticles loaded with coenzyme Q10 and preparation method thereof |
| 09/16/2009 | CN101530393A Clindamycin phosphate lipidosome freeze-dried preparation and preparation method thereof |
| 09/16/2009 | CN101530392A Omeprazole sodium freeze-dried lipidosome preparation and preparation method thereof |
| 09/16/2009 | CN101530391A Creatine phosphate sodium lipidosome freeze-dried preparation and preparation method thereof |
| 09/16/2009 | CN101530390A Preparation of Alpha-linolenic acid nanoliposome preparation and prescription |
| 09/16/2009 | CN101530389A Ginsenoside Rg 3 and phospholipid complex and preparing method thereof |
| 09/16/2009 | CN101530388A Formulation of mildronate injection and preparation method |
| 09/16/2009 | CN101530386A Gel with the active component being 11-hydroxy-oleanane-28-carboxylic acid methyl ester-2,12-diene |
| 09/16/2009 | CN101530253A Sachet with function of health care and use method thereof |
| 09/16/2009 | CN100540570C Devivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect |
| 09/16/2009 | CN100540560C Compounds that interact with kinases |
| 09/16/2009 | CN100540559C Lipoid compound regulator and use thereof |
| 09/16/2009 | CN100540558C High viscosity xanthan polymer preparations |
| 09/16/2009 | CN100540547C Inhibitors of histone deacetylase |
| 09/16/2009 | CN100540538C Large conductance calcium-activated k channel opener |
| 09/16/2009 | CN100540526C Methods for synthesis of acyloxyalkyl derivatives of GABA analogs |
| 09/16/2009 | CN100540523C Novel L-2-(alpha-hydroxy pentyl)benzoate and its preparation method and use |
| 09/16/2009 | CN100540063C Articles comprising mint odor-free cooling agent |
| 09/16/2009 | CN100540059C Rotavirus gene vaccine based on NSP4 gene |
| 09/16/2009 | CN100540055C Biodegradable block copolymeric compositions for drug delivery |
| 09/16/2009 | CN100540010C Use of beta-glucans against biological warfare weapons and pathogens including anthrax |
| 09/16/2009 | CN100540009C Oral puerarin phosphate compound capsule and preparing method |
| 09/16/2009 | CN100540008C Release delayed solid oral prophylactic or pregnancy stopping pill and its use |
| 09/16/2009 | CN100540007C Dihydrate dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compositions thereof |
| 09/16/2009 | CN100540006C Platinum derivative pharmaceutical formulations |
| 09/16/2009 | CN100540005C Tricyclic 1-((3-indol-3-yl)carbonyl)piperazine derivatives as cannabinoid cb1 receptor agonists |
| 09/16/2009 | CN100540004C Nasal pharmaceutical composition of piribedil |
| 09/16/2009 | CN100540003C Medicinal composition containing amlodipine and terazosine |
| 09/16/2009 | CN100540002C Use of hydrochloride coculine for preparing medicine to treat glioma |
| 09/16/2009 | CN100540001C Combinations comprising an antidiarrheal agent and an epothilone or an epothilone derivative |
| 09/16/2009 | CN100540000C Pharmaceutical compositions comprising ascorbic acid for the treatment of fungal double infection and fungal recurrences |
| 09/16/2009 | CN100539999C Compound formulation for reducing weight, fat, sugar, pressure and for preventing and treating osteoporosis |
| 09/16/2009 | CN100539998C Preparation method of multi-type superfine naproxen medcine granule |
| 09/15/2009 | US7589239 Therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders |
| 09/15/2009 | US7589238 Treatment of hyperphosphatemia using crosslinked small molecule amine polymers |